Study brings diagnostics for viruses a step closer to reality

February 14, 2012

Scientists have developed a technique which could form the basis of a non-invasive diagnostic for Adenovirus – the virus responsible for a large number of common illnesses.

The biosensor technology developed by researchers at the University of Leeds can not only detect the presence of the virus, it can also identify the individual strain and the number of virus particles present.

The study underpinning this research is published on Feb. 15 in the journal Biosensors & Bioelectronics.

Currently, testing for viruses is complicated, time consuming and requires specialist preparation of samples to identify virus DNA. Using this new technique, testing for viruses could be much quicker, simpler and ultimately less costly. For patients, this sort of diagnostic would mean faster treatment.

"This is a significant leap forward in testing for viruses," says Professor Paul Millner of the University's Faculty of Biological Sciences, who supervised the study. "For the first time we've been able to test for the presence of a whole virus, rather than having to seek out its genetic material, and the first time the number of virus particles has been counted using a device. These are both exciting developments."

is a common virus found in vertebrates and causes many illnesses, from the common cold through to gastroenteritis. People with strong immune systems are not badly affected by the virus, but for those with a compromised or immature immune system - such as small children or HIV sufferers– it can have fatal consequences.

The new technique uses antibodies attached to an electrical sensor. By measuring the sensor's electrical changes, researchers were able to identify how many virus particles were present, and determine the type of dependent on its response.

"There's a long way to go before the technology might reach a doctor's surgery, but we've proven the concept," says Rebecca Caygill, the PhD student behind the study. "We now need to increase the sensitivity of the test and optimise the different stages of the process so that we can consider scaling it up for clinical trials."

Explore further: Molecular anatomy of influenza virus detailed

More information: This study is published online by the journal Biosensors & Bioelectronics in a paper entitled: Novel impedimetric immunosensor for the detection and quantitation of adenovirus using reduced antibody fragments immobilized onto a conducting copolymer surface.

Related Stories

Molecular anatomy of influenza virus detailed

December 30, 2006

Scientists at the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), part of the National Institutes of Health in Bethesda, Md., and colleagues at the University of Virginia in Charlottesville ...

Structure of hepatitis B virus mapped

July 28, 2008

Using a newly developed method, Utrecht University researchers have mapped the structure and composition of the hepatitis B virus. The researchers were able to map the structure by spraying the virus.

Why do some influenza virus subtypes die out?

November 14, 2011

Every so often we hear about a new strain of influenza virus which has appeared and in some cases may sweep across the globe in a pandemic, much as the H1N1 virus did last year. What happens to the old seasonal viruses? In ...

Spotted under the microscope: How a virus puts on its armor

January 31, 2012

Scientists from VU University Amsterdam, Scripps Research Institute and the University of Michigan discovered how a virus 'puts on its armor'. This 'armor', consisting of mere proteins, is initially flexible and weak, but ...

Recommended for you

A new form of real gold, almost as light as air

November 25, 2015

Researchers at ETH Zurich have created a new type of foam made of real gold. It is the lightest form ever produced of the precious metal: a thousand times lighter than its conventional form and yet it is nearly impossible ...

Moonlighting molecules: Finding new uses for old enzymes

November 27, 2015

A collaboration between the University of Cambridge and MedImmune, the global biologics research and development arm of AstraZeneca, has led researchers to identify a potentially significant new application for a well-known ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.